Pilot study on the effect of flavonoids on arterial stiffness and oxidative stress in chronic kidney disease

Table 2 Baseline laboratory tests of the study population

Parameter	Value
Hct, %	42.3 ± 5.2
Hb, g/dL	14.3 ± 1.9
PLT, 103/μL	222 ± 51
Urea, mg/dL	51 (26, 70)
Creatinine, mg/dL	1.3 (0.77, 1.52)
Urine albumin, mg/24 h	183 (91.2, 949.0)
Sodium, mmol/L	139 ± 2
Potassium, mmol/L	4.9 (4.72, 5.00)
LDH, IU/L	183 ± 43
AST, IU/L	23 (15, 27)
ALT, IU/L	30 (18, 37)
Total serum protein, g/dL	6.7 ± 0.7
Serum albumin, g/dL	3.9 ± 0.8
Total cholesterol, mg/dL	152 ± 41
LDL-C, mg/dL	80 ± 31
Triglycerides, mg/dL	148 ± 59
Uric acid, mg/dL	5.8 ± 1.6
Calcium, mg/dL	9.6 (9.4, 9.9)
PTH, pg/mL	68 (40, 72)
CRP, mg/dL	0.52 (0.06, 0.31)
Fe, mg/dL	86 ± 32
Ferritin, ng/mL	201 (97, 299)
TIBC, mg/dL	288 (241, 341)
HbA1c, %	7.58 ± 1.63

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CRP: C reactive protein; Hb: Hemoglobin; HbA1c: Glycated hemoglobin; Hct: Hematocrit; LDH: Lactate dehydrogenase; LDL-C: Low-density lipoprotein-cholesterol; PLT: Platelet; PTH: Parathyroid hormone; TIBC: Total iron binding capacity.